TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0310
+0.0010 (3.33%)
Feb 12, 2026, 4:10 PM AEST
TrivarX Market Cap
TrivarX has a market cap or net worth of 34.61 million as of February 11, 2026. Its market cap has increased by 365.33% in one year.
Market Cap
34.61M
Enterprise Value
33.53M
Revenue
1.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since July 2, 2001, TrivarX's market cap has increased from 11.57M to 34.61M, an increase of 199.17%. That is a compound annual growth rate of 4.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 34.61M | 57.89% |
| Dec 31, 2025 | 21.92M | 194.71% |
| Dec 30, 2024 | 7.44M | -26.66% |
| Dec 29, 2023 | 10.14M | 52.72% |
| Dec 28, 2022 | 6.64M | -41.41% |
| Dec 30, 2021 | 11.34M | 5.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmX Technologies | 80.93M |
| Singular Health Group | 69.45M |
| Beamtree Holdings | 49.40M |
| PainChek | 49.12M |
| Emyria | 44.36M |
| Vitasora Health | 39.02M |
| ImExHS | 24.32M |
| Resonance Health | 20.42M |